Literature DB >> 19911183

Chronic bilious vomiting in children in developing countries due to high bowel obstruction: not always malrotation or tuberculosis.

Anand Pandey1, V Kumar, A N Gangopadhyay, S P Sharma, S C Gopal, D K Gupta, S C U Patne.   

Abstract

BACKGROUND: Bilious vomiting, in conjunction with abdominal pain is considered to be a surgical problem, unless proved otherwise. In children, besides tuberculosis (TB), we have found jejunal stricture (JS) due to non-specific jejunoileitis (NSJI) to be an important cause of chronic high small bowel obstruction and bilious vomiting.
MATERIALS AND METHODS: In this retrospective study, the records of all children with complaint of intermittent bilious vomiting and failure to thrive were evaluated. Investigations included oral contrast study, ultrasound abdomen, chest X-ray and Mantoux test. Final confirmation was made at laparotomy. Treatment included jejuno-jejunal resection and anastomosis. Histopathology of the specimen was done to look for caseation, granuloma formation and other details.
RESULTS: Out of total 100 patients with the complaint of bilious vomiting, 25 were having JS. Radiologic confirmation was possible in 19 (76%) patients of JS. No patient had evidence of TB as per our protocol. Histopathology revealed non-specific ischemic changes in all specimens.
CONCLUSION: Jejunal stricture due to NSJI is a common entity in our setup leading to bilious vomiting. Contrast study can provide high index of suspicion in most of the patients. The diagnosis must be confirmed after proper histopathological examination. The results of the surgery are excellent.

Entities:  

Mesh:

Year:  2010        PMID: 19911183     DOI: 10.1007/s00383-009-2527-3

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  24 in total

1.  Acute segmental enteritis.

Authors:  U K Singh; P Ojha; R K Sinha; S Suman
Journal:  Indian Pediatr       Date:  1998-08       Impact factor: 1.411

Review 2.  Proximal Crohn's disease: review of the clinicopathologic features and therapy.

Authors:  R A van Hogezand; A M Witte; R A Veenendaal; M J Wagtmans; C B Lamers
Journal:  Inflamm Bowel Dis       Date:  2001-11       Impact factor: 5.325

3.  Necrotizing enteritis in children. Part II. Pathology and pathogenesis.

Authors:  T C Parvathy; K K Varma
Journal:  Indian Pediatr       Date:  1982-06       Impact factor: 1.411

4.  Small bowel obstruction due to adhesions following neonatal laparotomy.

Authors:  Muhammad S Choudhry; Hugh W Grant
Journal:  Pediatr Surg Int       Date:  2006-07-14       Impact factor: 1.827

5.  Segmental necrotising enterocolitis: pathological and clinical features of 22 cases in Bangladesh.

Authors:  T Butler; B Dahms; K Lindpaintner; M Islam; M A Azad; P Anton
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

6.  Radiographic features in ischemic jejunoileitis: serial changes and comparison with pathologic findings.

Authors:  M Iida; T Matsui; T Yao; A Iwashita; K Sakamoto; T Fuchigami; T Yao; M Fujishima
Journal:  Gastrointest Radiol       Date:  1992

7.  Necrotizing enteritis.

Authors:  B D Pujari; S G Deodhare
Journal:  Br J Surg       Date:  1980-04       Impact factor: 6.939

8.  Nonspecific jejunitis--a challenging problem in children.

Authors:  A K Sharma; N S Shekhawat; S Behari; S Chandra; K C Sogani
Journal:  Am J Gastroenterol       Date:  1986-06       Impact factor: 10.864

Review 9.  [Superior mesenteric artery syndrome].

Authors:  J P Bonnet; D Louis; P Foray
Journal:  Arch Pediatr       Date:  1995-04       Impact factor: 1.180

10.  High jejunal obstruction as a sequela of necrotizing enterocolitis.

Authors:  S O Choi; W H Park; J S Kang
Journal:  J Korean Med Sci       Date:  1991-06       Impact factor: 2.153

View more
  1 in total

1.  Radiological versus clinical evidence of malrotation: Role of laparoscopy/laparotomy in Indian scenario.

Authors:  Shasanka Shekhar Panda; Meely Panda; Rashmi Ranjan Das; Pankaj Kumar Mohanty
Journal:  J Minim Access Surg       Date:  2014-10       Impact factor: 1.407

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.